MASI - Masimo Corporation Common Stock -  [ ]

Ticker Details
Masimo Corporation Common Stock
Masimo Corp is a medical technology company. The company develops, manufactures, and markets noninvasive monitoring technologies. Its product includes noninvasive blood constituent and brain and breath monitoring.
IPO Date: August 8, 2007
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $9.34B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.30 | 1.42%
Avg Daily Range (30 D): $0.25 | 0.14%
Avg Daily Range (90 D): $1.35 | 0.97%
Institutional Daily Volume
Avg Daily Volume: .45M
Avg Daily Volume (30 D): 1.37M
Avg Daily Volume (90 D): 1.16M
Trade Size
Avg Trade Size (Sh.): 71
Avg Trade Size (Sh.) (30 D): 61
Avg Trade Size (Sh.) (90 D): 60
Institutional Trades
Total Institutional Trades: 9,164
Avg Institutional Trade: $5.27M
Avg Institutional Trade (30 D): $12.28M
Avg Institutional Trade (90 D): $9.95M
Avg Institutional Trade Volume: .05M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $8.19M
Avg Closing Trade (30 D): $35.68M
Avg Closing Trade (90 D): $25.01M
Avg Closing Volume: 65.15K
 
News
Apr 1, 2026 @ 6:06 PM
SHAREHOLDER ALERT: The M&A Class Action Firm Conti...
Source: Monteverde & Associates Pc
Mar 22, 2026 @ 5:36 PM
This $7 Million Masimo Exit Came Before a 34% Surg...
Source: Jonathan Ponciano
Feb 25, 2026 @ 7:03 PM
SHAREHOLDER ALERT: The M&A Class Action Firm Is In...
Source: Prnewswire
Feb 19, 2026 @ 6:48 PM
Halper Sadeh LLC is Investigating Whether VRME, MA...
Source: Halper Sadeh Llc
Feb 18, 2026 @ 6:44 PM
Danaher's Masimo Acquisition: Solid Financials, Co...
Source: Vandana Singh
Financials
  TTM FY 2025 Q3 2026
Basic EPS $-2.83 $-1.86
Diluted EPS $-2.8 $-1.84
Revenue $1.53B $371.5M
Gross Profit $945.2M $230.6M
Net Income / Loss $-151.5M $-100.4M
Operating Income / Loss $310M $83.6M
Cost of Revenue $581.7M $140.9M
Net Cash Flow $-28.1M $118.3M
PE Ratio